FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/01/062007 [Registered on: 30/01/2024] Trial Registered Prospectively
Last Modified On: 25/01/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Comparative Study of Dexmedetomidine, Dexamethasone, and Clonidine Drugs With Ropivacaine in Upper Limb Surgery Under Supraclavicular Brachial Plexus Block. 
Scientific Title of Study   "A Clinical Comparative Study Of Dexmedetomidine, Dexamethasone And Clonidine As Adjuvants To Local Anaesthetics In Supraclavicular Brachial Plexus Block." 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  UMESH PRASAD YADAV 
Designation  PG Resident Anesthesiology 
Affiliation  Gajra Raja Medical College, Gwalior M.P. 
Address  Department of anaesthesiology JAH Campus Gwalior M.P.

Gwalior
MADHYA PRADESH
474001
India 
Phone  9752048204  
Fax    
Email  drumeshyadav0707@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR JITENDRA AGRAWAL 
Designation  Professor 
Affiliation  Gajra Raja Medical College, Gwalior M.P. 
Address  Department of Anesthesiology and JAH Campus Gwalior

Gwalior
MADHYA PRADESH
474001
India 
Phone  9300009942  
Fax    
Email  drjagrawal9@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR JITENDRA AGRAWAL 
Designation  Professor 
Affiliation  Gajra Raja Medical College, Gwalior M.P. 
Address  Department of Anesthesiology and JAH Campus Gwalior

Gwalior
MADHYA PRADESH
424001
India 
Phone  9300008842  
Fax    
Email  drjagrawal9@gmail.com  
 
Source of Monetary or Material Support  
GAJRA RAJA MEDICAL COLLEGE GWALIOR M.P. 
 
Primary Sponsor  
Name  UMESH PRASAD YADAV 
Address  Department of anaesthesiology JAH CAMPUS GWALIOR M.P. 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL   
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Jitendra Agrawal  Gajra Raja Medical College And Hospital Gwalior M.P.  Department of anaesthesiology, Gajra Raja Medical College Gwalior M.P.
Gwalior
MADHYA PRADESH 
9300009942

drjagrawal9@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
GAJRA RAJA MEDICAL COLLEGE GWALIOR M.P.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: S520||Fracture of upper end of ulna, (2) ICD-10 Condition: S521||Fracture of upper end of radius, (3) ICD-10 Condition: S522||Fracture of shaft of ulna, (4) ICD-10 Condition: S523||Fracture of shaft of radius, (5) ICD-10 Condition: S525||Fracture of lower end of radius, (6) ICD-10 Condition: S526||Fracture of lower end of ulna, (7) ICD-10 Condition: S518||Open wound of forearm,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Clonidine with Lignocaine-Adrenaline To Ropivacaine   Clonidine(1micro/kg) (2ml) with Lignocaine-Adrenaline (10ml) To Ropivacaine (0.5%) (20ml) (Total Volume 32ml)In Supraclavicular Brachial Plexus Block.(30 patient each of total duration 18 months) 
Comparator Agent  Dexamethasone with Lignocaine-Adrenaline TO Ropivacaine   Dexamethasone 2ml (8mg) with Lignocaine-Adrenaline (10ml) Ropivacaine (0.5%) (20ml) (Total Volume 32 ml) In Supraclavicular Brachial Plexus Block.(30 patient each of total duration 18 months)  
Comparator Agent  Dexmedetomidine with Lignocaine-Adrenaline To Ropivacaine   Dexmedetomidine (2ml) (1micro/kg) with Lignocaine-Adrenaline (10ml) To Ropivacaine (0.5%) (20ml) (Total Volume 32ml) In Supraclavicular Brachial Plexus Block.(30 patient each of total duration 18 months) 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  90 Patients ASA Grade I and II
 
 
ExclusionCriteria 
Details  History of allergy or any other reaction to local anesthetics
Hypertensive patients
Renal dysfunction
Cardiac disease
Bleeding disorder
Deranged LFT
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Double Blind Double Dummy 
Primary Outcome  
Outcome  TimePoints 
In The Upper Extremity Surgeries Performed Under Supraclavicular Block Dexmedetomidine is Superior to Clonidine and Dexamethasone due to its Prolonged duration of analgesia, faster onset of action and better quality of sensory and motor block   Baseline 
 
Secondary Outcome  
Outcome  TimePoints 
nil  nil 
 
Target Sample Size   Total Sample Size="90"
Sample Size from India="90" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   05/02/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="8"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

       To evaluate and compare the onset and duration of sensory and motor blockade of 0.5% Ropivacaine with Dexmedetomidine,           Dexamethasone and Clonidine in supraclavicular brachial plexus blockade.

       Dexmedetomidine as adjuvant to local anesthetic in supra clavicular block may provide faster onset , prolonged duration of block and better quality of analgesia.


 
Close